Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function.

Berthon A, Faucz FR, Espiard S, Drougat L, Bertherat J, Stratakis CA.

Hum Mol Genet. 2017 Sep 15;26(18):3495-3507. doi: 10.1093/hmg/ddx235.

PMID:
28911199
2.

Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?

Drougat L, Espiard S, Bertherat J.

Eur J Endocrinol. 2015 Oct;173(4):M121-31. doi: 10.1530/EJE-15-0532. Epub 2015 Aug 11. Review.

3.

Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma.

Lefèvre L, Omeiri H, Drougat L, Hantel C, Giraud M, Val P, Rodriguez S, Perlemoine K, Blugeon C, Beuschlein F, de Reyniès A, Rizk-Rabin M, Bertherat J, Ragazzon B.

Oncogenesis. 2015 Jul 27;4:e161. doi: 10.1038/oncsis.2015.20.

4.

Novel Insights into the Genetics and Pathophysiology of Adrenocortical Tumors.

Drougat L, Omeiri H, Lefèvre L, Ragazzon B.

Front Endocrinol (Lausanne). 2015 Jun 9;6:96. doi: 10.3389/fendo.2015.00096. eCollection 2015. Review.

5.

ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.

Espiard S, Drougat L, Libé R, Assié G, Perlemoine K, Guignat L, Barrande G, Brucker-Davis F, Doullay F, Lopez S, Sonnet E, Torremocha F, Pinsard D, Chabbert-Buffet N, Raffin-Sanson ML, Groussin L, Borson-Chazot F, Coste J, Bertagna X, Stratakis CA, Beuschlein F, Ragazzon B, Bertherat J.

J Clin Endocrinol Metab. 2015 Jun;100(6):E926-35. doi: 10.1210/jc.2014-4204. Epub 2015 Apr 8.

6.

Primary Aldosteronism and ARMC5 Variants.

Zilbermint M, Xekouki P, Faucz FR, Berthon A, Gkourogianni A, Schernthaner-Reiter MH, Batsis M, Sinaii N, Quezado MM, Merino M, Hodes A, Abraham SB, Libé R, Assié G, Espiard S, Drougat L, Ragazzon B, Davis A, Gebreab SY, Neff R, Kebebew E, Bertherat J, Lodish MB, Stratakis CA.

J Clin Endocrinol Metab. 2015 Jun;100(6):E900-9. doi: 10.1210/jc.2014-4167. Epub 2015 Mar 30.

7.

Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation.

Faucz FR, Zilbermint M, Lodish MB, Szarek E, Trivellin G, Sinaii N, Berthon A, Libé R, Assié G, Espiard S, Drougat L, Ragazzon B, Bertherat J, Stratakis CA.

J Clin Endocrinol Metab. 2014 Jun;99(6):E1113-9. doi: 10.1210/jc.2013-4280. Epub 2014 Mar 6.

8.

Antibodies and activity measurements for the detection of O-GlcNAc transferase and assay of its substrate, UDP-GlcNAc.

Lefebvre T, Drougat L, Olivier-Van Stichelen S, Michalski JC, Vercoutter-Edouart AS.

Methods Mol Biol. 2013;1022:147-59. doi: 10.1007/978-1-62703-465-4_12. Review.

PMID:
23765660
9.

Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition.

Drougat L, Olivier-Van Stichelen S, Mortuaire M, Foulquier F, Lacoste AS, Michalski JC, Lefebvre T, Vercoutter-Edouart AS.

Biochim Biophys Acta. 2012 Dec;1820(12):1839-48. doi: 10.1016/j.bbagen.2012.08.024. Epub 2012 Sep 3.

PMID:
22967762
10.

Serum-stimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expression.

Olivier-Van Stichelen S, Drougat L, Dehennaut V, El Yazidi-Belkoura I, Guinez C, Mir AM, Michalski JC, Vercoutter-Edouart AS, Lefebvre T.

Oncogenesis. 2012 Dec 10;1:e36. doi: 10.1038/oncsis.2012.36.

11.

Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease.

Lefebvre T, Dehennaut V, Guinez C, Olivier S, Drougat L, Mir AM, Mortuaire M, Vercoutter-Edouart AS, Michalski JC.

Biochim Biophys Acta. 2010 Feb;1800(2):67-79. doi: 10.1016/j.bbagen.2009.08.008. Epub 2009 Sep 2. Review.

PMID:
19732809

Supplemental Content

Loading ...
Support Center